Source: MarketScreener

SanBio Co., Ltd.: SanBio : Notice on the recording of other comprehensive income, non-operating income, and non-operating expenses

(marketscreener.com) December 15, 2021 Company name: SanBio Co., Ltd. ...https://www.marketscreener.com/quote/stock/SANBIO-COMPANY-LIMITED-21453260/news/SanBio-Notice-on-the-recording-of-other-comprehensive-income-non-operating-income-and-non-operat-37325095/?utm_medium=RSS&utm_content=20211215

Read full article »

SanBio Co., Ltd.'s Competitors | SanBio Co., Ltd.'s News | SanBio Co., Ltd.'s Financials

Followers on Owler

Annual Revenue

$5.0-25M

Employees

25-100

Co-CEO

Keita Mori

CEO Approval Rating

71/100

SanBio is a pharmaceutical company that engages in the research and development of regenerative medicines for the treatment of neurological disorders.